These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1572 related articles for article (PubMed ID: 22275317)

  • 1. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines.
    Litvan I; Goldman JG; Tröster AI; Schmand BA; Weintraub D; Petersen RC; Mollenhauer B; Adler CH; Marder K; Williams-Gray CH; Aarsland D; Kulisevsky J; Rodriguez-Oroz MC; Burn DJ; Barker RA; Emre M
    Mov Disord; 2012 Mar; 27(3):349-56. PubMed ID: 22275317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI.
    Litvan I; Aarsland D; Adler CH; Goldman JG; Kulisevsky J; Mollenhauer B; Rodriguez-Oroz MC; Tröster AI; Weintraub D
    Mov Disord; 2011 Aug; 26(10):1814-24. PubMed ID: 21661055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of diagnostic criteria and assessments for Parkinson's disease mild cognitive impairment.
    Goldman JG; Holden SK; Litvan I; McKeith I; Stebbins GT; Taylor JP
    Mov Disord; 2018 Apr; 33(4):503-510. PubMed ID: 29488270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease.
    Goldman JG; Holden S; Bernard B; Ouyang B; Goetz CG; Stebbins GT
    Mov Disord; 2013 Dec; 28(14):1972-9. PubMed ID: 24123267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An assessment of Movement Disorder Society Task Force diagnostic criteria for mild cognitive impairment in Parkinson's disease.
    Uysal-Cantürk P; Hanağası HA; Bilgiç B; Gürvit H; Emre M
    Eur J Neurol; 2018 Jan; 25(1):148-153. PubMed ID: 28941002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial cognitive changes in Parkinson's disease.
    Weintraub D; Tröster AI; Marras C; Stebbins G
    Mov Disord; 2018 Apr; 33(4):511-519. PubMed ID: 29543342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the utility of the Movement Disorder Society Task Force Level 1 diagnostic criteria for mild cognitive impairment in Parkinson's disease.
    Szeto JY; Mowszowski L; Gilat M; Walton CC; Naismith SL; Lewis SJ
    Parkinsonism Relat Disord; 2015 Jan; 21(1):31-5. PubMed ID: 25465744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's disease mild cognitive impairment: application and validation of the criteria.
    Geurtsen GJ; Hoogland J; Goldman JG; Schmand BA; Tröster AI; Burn DJ; Litvan I;
    J Parkinsons Dis; 2014; 4(2):131-7. PubMed ID: 24296865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mild cognitive impairment in Parkinson's disease: Diagnosis and progression to dementia.
    Galtier I; Nieto A; Lorenzo JN; Barroso J
    J Clin Exp Neuropsychol; 2016; 38(1):40-50. PubMed ID: 26602176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mild cognitive impairment in Parkinson's disease].
    Wada K; Nakashima K
    Brain Nerve; 2012 Dec; 64(12):1365-75. PubMed ID: 23209063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive Impairments in Parkinson's disease.
    Nakashima K
    Nihon Rinsho; 2017 Jan; 75(1):101-104. PubMed ID: 30566302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of Parkinson's disease dementia related to level I MDS PD-MCI.
    Hoogland J; Boel JA; de Bie RMA; Schmand BA; Geskus RB; Dalrymple-Alford JC; Marras C; Adler CH; Weintraub D; Junque C; Pedersen KF; Mollenhauer B; Goldman JG; Tröster AI; Burn DJ; Litvan I; Geurtsen GJ;
    Mov Disord; 2019 Mar; 34(3):430-435. PubMed ID: 30653248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosing PD-MCI by MDS Task Force criteria: how many and which neuropsychological tests?
    Goldman JG; Holden S; Ouyang B; Bernard B; Goetz CG; Stebbins GT
    Mov Disord; 2015 Mar; 30(3):402-6. PubMed ID: 25449653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective assessment of movement disorder society criteria for mild cognitive impairment in Parkinson's disease.
    Loftus AM; Bucks RS; Thomas M; Kane R; Timms C; Barker RA; Gasson N
    J Int Neuropsychol Soc; 2015 Feb; 21(2):137-45. PubMed ID: 25666735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mild cognitive impairment in De Novo Parkinson's disease according to movement disorder guidelines.
    Poletti M; Frosini D; Ceravolo R; Bonuccelli U
    Mov Disord; 2012 Nov; 27(13):1706; author reply 1707. PubMed ID: 23192930
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnosing mild cognitive impairment in Parkinson's disease: which tests perform best in the Italian population?
    Federico A; Trentin M; Zanette G; Mapelli D; Picelli A; Smania N; Tinazzi M; Tamburin S
    Neurol Sci; 2017 Aug; 38(8):1461-1468. PubMed ID: 28550344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring mild cognitive impairment in patients with Parkinson's disease.
    Marras C; Armstrong MJ; Meaney CA; Fox S; Rothberg B; Reginold W; Tang-Wai DF; Gill D; Eslinger PJ; Zadikoff C; Kennedy N; Marshall FJ; Mapstone M; Chou KL; Persad C; Litvan I; Mast BT; Gerstenecker AT; Weintraub S; Duff-Canning S
    Mov Disord; 2013 May; 28(5):626-33. PubMed ID: 23520128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive function in the early phase of Parkinson's disease, a five-year follow-up.
    Domellöf ME; Ekman U; Forsgren L; Elgh E
    Acta Neurol Scand; 2015 Aug; 132(2):79-88. PubMed ID: 25644230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of mild cognitive impairment subtypes in Parkinson's disease.
    Cholerton BA; Zabetian CP; Wan JY; Montine TJ; Quinn JF; Mata IF; Chung KA; Peterson A; Espay AJ; Revilla FJ; Devoto J; Watson GS; Hu SC; Leverenz JB; Edwards KL
    Mov Disord; 2014 May; 29(6):756-64. PubMed ID: 24710804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Guidelines for the Neuropsychological Assessment of Patients with Parkinson's Disease].
    Liepelt-Scarfone I; Gräber S; Kalbe E; Riedel O; Ringendahl H; Schmidt N; Witt K; Roeske S
    Fortschr Neurol Psychiatr; 2021 Jul; 89(7-08):363-373. PubMed ID: 33561875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 79.